Supplier of Hormonal and Specialty Medications

The contract seeks a supplier to provide low-volume, high-complexity pharmaceutical products, including hormonal therapies such as estradiol and testosterone, along with other controlled substances intended exclusively for specialized research purposes. These medications require precise formulation, strict regulatory compliance, and specialized handling due to their potency and classification. The solicitation is issued under the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services and is classified as a subcontract with a NAICS code of 325412, indicating manufacturing of pharmaceutical preparations. The opportunity was posted on May 4, 2026, with a firm deadline for responses on May 15, 2026, at 6:00 p.m. No set-aside provisions or geographic restrictions are specified, and the performance location remains undefined. Interested parties must demonstrate capability in producing and delivering highly regulated, low-volume pharmaceuticals under stringent quality and security protocols while meeting the unique demands of research-grade materials.